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http://dx.doi.org/10.1016/j.stemcr.2016.09.006SUMMARYThe transition of human embryonic stem cells (hESCs) from pluripotency to lineage commitment is not fully understood, and a role
for phenotypic transcription factors in the initial stages of hESC differentiation remains to be explored. From a screen of candidate
factors, we found that RUNX1 is selectively and transiently upregulated early in hESC differentiation to mesendodermal lineages. Tran-
scriptome profiling and functional analyses upon RUNX1 depletion established a role for RUNX1 in promoting cell motility. In parallel,
we discovered a loss of repression for several epithelial genes, indicating that loss of RUNX1 impaired an epithelial to mesenchymal tran-
sition during differentiation. Cell biological and biochemical approaches revealed that RUNX1 depletion specifically compromised
TGFB2 signaling. Both the decrease in motility and deregulated epithelial marker expression upon RUNX1 depletion were rescued by
reintroduction of TGFB2, but not TGFB1. These findings identify roles for RUNX1-TGFB2 signaling in early events of mesendodermal
lineage commitment.INTRODUCTION
Human embryonic stem cells (hESCs) have unlimited
replicative potential and are capable of differentiating
into cell types from each of the three germ layers (Thom-
son et al., 1998). While much is known about the mainte-
nance of pluripotency (Boward et al., 2016; Boyer et al.,
2005; Chambers et al., 2003; Huang et al., 2015; Kapinas
et al., 2013), how differentiation signals regulate the
dissolution of pluripotency and the establishment of
phenotype is not well understood. Studies in hESCs
have shown that many genes responsible for early devel-
opmental events are poised for either activation or repres-
sion by epigenetic mechanisms (Bernstein et al., 2006;
Grandy et al., 2015; Szutorisz and Dillon, 2005). Once a
differentiation signal has been introduced, early factors
are expressed that prime the gene expression program of
cells for lineage acquisition (Zaret and Carroll, 2011). In
this study, we investigated whether phenotype-associated
transcription factors may play an initial role in differenti-
ation prior to their established function in specifying
lineage identity. A candidate screen of phenotypic tran-
scription factors identified RUNX1 as selectively and
transiently upregulated as early as 8 hr during mesendo-
dermal differentiation of hESCs.
Members of the RUNX family of transcription factors
have known roles in development (Chuang et al.,
2013): RUNX1 is necessary for definitive hematopoiesis
(Okuda et al., 1996), RUNX2 for bone formation (Otto884 Stem Cell Reports j Vol. 7 j 884–896 j November 8, 2016 j ª 2016 The
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vous system development (Inoue et al., 2002; Levanon
et al., 2002; Li et al., 2002). When genetically deleted
in mice, Runx1 causes embryonic lethality due to major
defects in the formation of the fetal liver and hemorrhag-
ing in the CNS (Okuda et al., 1996; Wang et al., 1996).
Emerging evidence suggests that RUNX1 has roles in
non-hematopoietic lineages (Osorio et al., 2008; Scheitz
and Tumbar, 2013; Stifani et al., 2008). Our discovery
of transient upregulation of RUNX1 points to a role
for RUNX1 during early mesendodermal differentiation
of hESCs.
We investigated what role the early expressed pheno-
typic transcription factor RUNX1might play during differ-
entiation in addition to its known role in association with
hematopoietic lineage identity. Genome-wide transcrip-
tome analysis of RUNX1-depleted hESCs revealed that
RUNX1 positively regulates transforming growth factor
b2 (TGFB2) signaling and themotility of the differentiating
hESCs. Importantly, genes associated with the epithelial
to mesenchymal transition (EMT) were affected, with
epithelial gene expression increasing in the absence of
RUNX1. Exogenous reintroduction of TGFB2, but not
TGFB1, ameliorates the effect of RUNX1 depletion on cell
motility and the EMT process. Taken together, our results
show that the selective and transient expression of
RUNX1 during early hESC differentiation tomesendoderm
promotes EMT and motility through regulation of the
TGFB2 signaling pathway.Authors.
ns.org/licenses/by/4.0/).
RESULTS
RUNX1 Is Transiently and Selectively Upregulated
during Early Mesendodermal Differentiation of
Human Embryonic Stem Cells
To investigate whether phenotype-associated transcription
factors play a role in early hESC differentiation prior to
their established role in control of lineage identity, we
screened expression of candidate transcription factors
using qRT-PCR analysis. We induced mesendodermal dif-
ferentiation (Figure 1A) as described in Experimental
Procedures, and ensured mesendodermal commitment of
hESCs by evaluating the expression of known mesendo-
derm markers (Mahmood and Aldahmash, 2015; Tada
et al., 2005; VanOudenhove et al., 2016). As expected T,
MIXL1, and MESP1 were upregulated (Figure 1B). We
discovered RUNX1was the only candidate factor selectively
and transiently upregulated as early as 4–8 hr following
induction of differentiation (Figure 1C).
Different RUNX1 isoforms (Figure 1D) are linked to
distinct biological processes (Brady et al., 2013; Challen
and Goodell, 2010; Ran et al., 2013). Importantly, the
RUNX1c isoform, transcribed from the P1 promoter, is
expressed at the time of emergence of definitive hemato-
poietic precursors, while RUNX1b, transcribed from the
P2 promoter, is more widely expressed (Sroczynska et al.,
2009). Therefore, we used specific primers to examine
relative levels of each RUNX1 isoform. We discovered that
the RUNX1b isoform was the predominantly expressed
transcript in two different hESC lines, the female H9
and male H1, during mesendodermal differentiation
(Figure 1D).
We next examined the levels of total RUNX1 transcripts
during endodermal (D’Amour et al., 2005), mesodermal
(Lian et al., 2013), and ectodermal (Tonge and Andrews,
2010)differentiationofhESCs todeterminewhether expres-
sion is lineage specific (Figure 1E); lineages were confirmed
using markers as previously described (VanOudenhove
et al., 2016). RUNX1was expressed during both endodermal
and mesodermal, but not ectodermal differentiation, con-
firming the mesendodermal specificity. Furthermore, RNA
FISH (fluorescence in situ hybridization) revealed that
>98% of colonies and >95% of cells exhibited RUNX1
expression during mesendodermal differentiation (Fig-
ure1F). Themajorityof cellshad twonuclear foci, consistent
with two sites of transcription. In agreement with the RNA
expression data, there was a complete lack of RUNX1 foci
in undifferentiated hESCs (Figure 1F). These findings estab-
lish that RUNX1 transcripts are transiently and selectively
expressed in mesendodermal lineage commitment.
Because several post-transcriptional mechanisms can
prevent translation (Jackson et al., 2010), we investigated
whether the RUNX1 RNA was translated into protein.Both H1 and H9 hESC lines were subjected to early mesen-
dodermal differentiation. Western blot analysis showed
that RUNX1 protein was detectable by 12 hr, peaked at
48 hr, and decreased by 96 hr (Figure 1G). As expected,
levels of the pluripotencymarker POU5F1 decreased during
differentiation (Figure 1G). Since RUNX1 protein is func-
tionally organized in punctate nuclear foci (Zeng et al.,
1997, 1998), we investigated its localization using immu-
nofluorescence (IF) microscopy (Figure 1H). Undifferenti-
ated hESCs were devoid of RUNX1 protein, but robust
nuclear staining was detected in >90% of cells by 48 hr,
which corroborates the RNA expression and FISH results.
Taken together, these findings demonstrate that RUNX1
upregulation is specific for early differentiation toward
mesendodermal lineages.
RUNX1 Regulates Cell Motility and EMT in
Differentiating hESCs
To determine the functional role of RUNX1, we performed
global gene expression profiling during early mesendoder-
mal differentiation of hESCs in which RUNX1 had been
depleted (Figure 2A). Knockdown of RUNX1was confirmed
by western blot (Figure 2B), and microarray analysis was
performed on total cellular RNA from uninfected, non-
silencing (shNS) and RUNX1-depleted (shRUNX1) hESCs
at four time points (0 hr, 8 hr, 24 hr, 72 hr) (Figure 2A).
Reproducibility of gene expression datasets from three in-
dependent experiments was demonstrated by principal
component analysis, which shows the undifferentiated
and differentiated hESC samples in distinct clusters. As
differentiation progresses, shRUNX1 samples separate
away from the control samples (uninfected and shNS)
(Figure 2A). Bioinformatics analyses determined that the
non-silencing small hairpin RNA (shRNA) had very little ef-
fect on the time course of differentiation. Upon RUNX1
knockdown, only a small number of genes were signifi-
cantly changed (1.5-fold change with a p value %0.05
and false discovery rate [FDR] p value%0.05) by 8 hr of dif-
ferentiation (n = 31). The number of genes that were
changed continued to increase by 24 hr (n = 334) and
72 hr (n = 435) (Figure 2C and Table S2). These observations
indicate that the depletion of RUNX1 affects gene expres-
sion and suggest a functional role for RUNX1 in early
hESC differentiation.
We investigated which biological processes were altered
by RUNX1 knockdown during mesendodermal differ-
entiation. Functional grouping of gene ontology (GO)
annotations showed that three biological processes were
potentially affected: regulation of endothelial cell prolifer-
ation, smooth muscle cell migration, and cell adhesion
(Figure 2D). We experimentally addressed contributions
of RUNX1 in the regulation of these processes. Proliferation
was assessed by measuring growth curves of pluripotent orStem Cell Reports j Vol. 7 j 884–896 j November 8, 2016 885
Figure 1. RUNX1 Is Transiently Upregulated during Early Differentiation of Human Embryonic Stem Cells to Mesendodermal
Lineages
(A) Phase-contrast images of hESCs before differentiation and after 24 hr of mesendodermal differentiation. In the undifferentiated state
the cells appear more epithelial-like, but after 24 hr of differentiation they appear more mesenchymal-like. Images were taken at
103 magnification.
(B) Diagram of gene expression profile of early mesendodermal differentiation of hESCs.
(C) Relative transcript levels of select transcription factors, including the RUNX family, during early mesendodermal differentiation of
hESCs. Graph represents mean ± SEM from three independent experiments.
(D) Relative levels of the RUNX1 isoforms in both the female (H9) and male (H1) hESCs with a schematic of different RUNX1 transcript
isoforms. Graph represents mean ± SEM from three independent experiments.
(E) Relative levels of total RUNX1 transcript during directed differentiation to the three germ layers. No RUNX1 transcript was detected
during ectoderm differentiation. Data represent the mean ± SEM values from three independent experiments.
(F) Representative RNA FISH images showing RUNX1 RNA (red) at time points indicated. Nuclei are stained with DAPI (blue). Images taken
at 633 magnification.
(G) Representative western blot showing the transient increase in levels of RUNX1, and the decrease in POU5F1 in the H1 and H9 hESCs
during a mesendoderm differentiation time course with CDK2 used as the loading control.
(H) Representative immunofluorescence images showing RUNX1 (green) nuclear staining at the time points indicated. Nuclei are stained
with DAPI (blue). Images taken at 633 magnification.
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Figure 2. Knockdown of RUNX1 Impairs the Migration Ability, but Not the Proliferation Rate, of hESCs during Mesendoderm
Differentiation
(A) Principal component analysis of the time points, replicates, and treatments for mesendodermal differentiation of hESCs from tran-
scriptome profiling. Four time points (undifferentiated [0h; red], 8 hr [8h; purple], 1 day [24h; blue], and 3 days [72h; green]) (n = 3
replicates from independent experiments) were analyzed by microarray analysis under three different treatments (uninfected [squares],
non-silencing infected [triangles], and shRUNX1 [circles]).
(legend continued on next page)
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differentiating uninfected, shNS, or shRUNX1 hESCs
(Figure 2E). RUNX1 depletion had no net effect on pro-
liferation when compared with the two controls. This
observation was further confirmed by measuring active
DNA synthesis using 5-bromo-2-deoxyuridine (BrdU)
incorporation (Figure 2F), which showed no effect of
RUNX1 knockdown on the percentage of BrdU- positive
cells in pluripotent or differentiating hESCs.
The effect of RUNX1 on the migration of differentiating
hESCs was examined by scratch closure assays (Figures 2G
and 2H). The extent of scratch closure was measured 18 hr
after scratch initiation (Figure 2G). Uninfected and shRNA
control cells achieved 70% closure, while the shRUNX1
cells achieved only 40% closure (Figure 2H), indicating
impaired migration upon RUNX1 depletion. Taken
together with the lack of RUNX1 effect on proliferation,
these findings establish a role for RUNX1 in regulating
migration during early mesendodermal differentiation.
Consistent with these results, GO term analysis using
DAVID revealed that genes upregulated upon knockdown
of RUNX1 were involved in cell-cell adhesion and junction
interactions (Figure S1A). In addition, many of the top
genes that were increased upon RUNX1 depletion during
differentiation are associatedwith an epithelial-like pheno-
type (Figure S1B). These findings led us to experimentally
test whether the EMT was affected by loss of RUNX1.
We evaluated the expression of several epithelial (CDH1
[Cadherin 1/E-Cadherin], OCLN [Occludin], and CLD7
[Claudin 7]) and mesenchymal (VIM [Vimentin], TWIST1
[Twist Family basic Helix-Loop-Helix Transcription Fac-
tor 1], ZEB2 [Zinc Finger E-box Binding Homeobox 2],
SNAI1 [Snail Family Transcriptional Repressor 1], SNAI2
[Snail Family Transcriptional Repressor 2], and CD44
[CD44 molecule (Indian Blood Group)]) marker genes
across early mesendodermal differentiation in either shNS(B) Representative western blot comparing the levels of RUNX1 in
differentiating to mesendoderm, confirming that RUNX1 is knocked d
(C) Venn diagram of the number of genes with expression changes gre
each differentiation time point under shRUNX1 treatment compared wi
at each time point is in brackets.
(D) ClueGO analysis of genes with significant expression changes re
knockdown.
(E) Growth curves for hESCs either uninfected (blue), non-silencing
mesendoderm differentiation conditions. Line graph represents mean
(F) Percentage of cells staining positive for BrdU with a 30-min pulse
scoring in duplicate of 200 cells from immunofluorescent images. Da
(G) Representative phase-contrast images from a scratch closure ass
differentiation cells were treated with mitomycin C (to inhibit prolife
later. Dotted lines have been added to the phase-contrast images for
phase-contrast images were taken at 103 magnification.
(H) Percentage of scratch closure for hESCs uninfected, non-silencin
plug-in. Ten scratches were measured for each condition, two from ea
***p < 0.001; NS, not significant.
888 Stem Cell Reports j Vol. 7 j 884–896 j November 8, 2016or shRUNX1 hESCs (Figure 3). A typical profile of cells
undergoing EMT is observed in shNS hESCs, where all
epithelial markers decreased and all mesenchymal markers
increased at some point during differentiation (Figure 3,
light gray bars). However, in the absence of RUNX1, the
epithelial markers decreased initially but were restored to
at least undifferentiated levels by 72 hr (Figure 3, black
bars). This is consistent with RUNX1, which is expressed
by 8 hr, assisting in the suppression of epithelial markers
during the early stages of EMT. In contrast, the majority
of mesenchymal markers were unaffected with the
exception of ZEB2, which was not induced (Figure 3, black
bars). Collectively these findings show that RUNX1 con-
tributes to regulation of a physiological EMT that occurs
during early mesendodermal differentiation.
RUNX1 Depletion Inhibits TGFB2 Signaling
Because EMT is a complex process regulated by multiple
signaling pathways (Derynck et al., 2014; Zhang et al.,
2016), we performed signaling pathway analysis on anno-
tated genes that changed significantly upon RUNX1
depletion (Figure 4A and Table S3). Distinct pathways
were suggested to be activated by RUNX1 knockdown at
each time point, althoughno single pathwaywas suggested
to be activated at all time points. Conversely, the TGFB
pathway was indicated to be the most inhibited across
the time course of differentiation (Figure 4A and Table
S3), which suggests that RUNX1 activates TGFB signaling
during mesendodermal differentiation.
To investigate directly how RUNX1 regulates the TGFB
signaling pathway, we examined expression of the TGFB
ligands upon RUNX1 depletion (Figure 4B). TGFB1 and
TGFB2 RNA exhibited sequential and significant upregula-
tion (>15 fold) during hESC differentiation, while TGFB3,
which is expressed at relatively low levels, remainedhESCs treated with either non-silencing shRNA or RUNX1 shRNA
own in shRUNX1 hESCs.
ater than 1.5-fold, and p value and FDR p values less than 0.05, at
th non-silencing infected hESCs. The total number of genes changed
veals three biological processes that might be affected by RUNX1
infected (red), or with shRUNX1 (green) under pluripotent and
± SEM from three independent experiments.
of labeling. Quantification of BrdU+ cells was performed using blind
ta represent mean ± SEM from three independent experiments.
ay. Cells were plated, differentiated for 48 hr, and after 46 hr of
ration) after which a scratch was made. Closure was measured 18 hr
emphasis along the edge of the scratch after that 18 h period. All
g infected, and infected with shRUNX1, as quantitated by ImageJ
ch of five independent experiments, and data represent mean ± SD.
Figure 3. Genes that Regulate Epithelial to Mesenchymal Transition Are Affected by RUNX1 Knockdown
During mesendoderm differentiation of hESCs, the levels of multiple effectors of EMT (epithelial associated [CDH1, OCLN, and CLD7] and
mesenchymal associated [VIM, TWIST1, ZEB2, SNAI1, SNAI2, and CD44]) were measured by qRT-PCR under treatment by non-silencing
infection, or shRUNX1. During the control (non-silencing) differentiation epithelial marker expression decreases and mesenchymal gene
expression increases. However, with shRUNX1 treatment, the epithelial marker genes fail to be suppressed and ZEB2 is not induced. Data
shown represent mean ± SEM from three independent experiments. p Values were determined by t test between non-silencing infected and
shRUNX1 treatment at each corresponding time point (*p < 0.001). See also Figure S1.unchanged. Importantly, only TGFB2 expression was
significantly affected by RUNX1 depletion (Figure 4B).
We also found that both TGFB1 and TGFB2, but not
TGFB3, promoters contain RUNX1 consensus sites within
1 kb of the transcription start site. We tested whether
RUNX1 binds to the TGFB promoters using chromatin
immunoprecipitation (ChIP)-qPCR. Our results show that
RUNX1 selectively occupies the TGFB2, but not the
TGFB1, promoter (Figure 4C), which is consistent with
the effect of RUNX1 depletion on TGFB2 expression (Fig-
ure 4B). As expected, RUNX1 occupied its own promoter,
which was included as a positive control (Knezevic et al.,
2011). These results show that RUNX1 selectively occupies
and regulates expression of the TGFB2 gene.
We next examined whether downstream effectors of the
canonical TGFB pathway were changed in the absence of
RUNX1. Western blot analysis was carried out for both
phospho- and total SMAD2 during mesendodermal differ-
entiation (Figures 4DandS2). In the control (non-silencing)time course, there was an increase in phospho-SMAD2 at
8 hr and 24 hr that decreased by 72 hr relative to total
SMAD2 (Figures 4D, S2A, and S2B). This increase coincides
with the expression of TGFB1 and TGFB2 ligands that both
signal through the SMADpathway (Figures 4B, 4D, and S2).
Quantitation of the ratio of phospho- to total SMAD2 re-
vealed a decrease at 24 hr and 72 hr, which is when
TGFB2 levels are decreased the most upon RUNX1 knock-
down (Figures 4D, 4E, and S2B). Together, these findings
show that RUNX1 is an upstream activator of TGFB2
signaling during early mesendodermal differentiation.
TGFB2 Rescues Impaired Cell Motility and Epithelial
Gene Expression Caused by RUNX1 Depletion
The TGFB pathway is known to regulate cell migration and
adhesion (Xu et al., 2009). Our findings revealed that
RUNX1 affects cell motility (Figure 2G) and specifically
regulates TGFB2 expression (Figure 4B). We directly tested
whether there is a connection between the defects inStem Cell Reports j Vol. 7 j 884–896 j November 8, 2016 889
Figure 4. Knockdown of RUNX1 Inhibits the TGFB Signaling Pathway, Specifically through TGFB2
(A) Top signaling pathways inhibited by RUNX1 knockdown as determined by Ingenuity Pathway analysis.
(B) Relative expression of the three TGFB ligands under non-silencing and shRUNX1 treatment by RT-qPCR. Data represent mean ± SEM
from three independent experiments with a p value determined by t test (*p < 0.05).
(C) ChIP-qPCR analysis for RUNX1 binding sites in the promoters of the TGFB1, TGFB2, and RUNX1 promoters. Experiments were carried out
at the peak of RUNX1 protein expression at 48 hr of differentiation. Data represent mean ± SEM of fold enrichment from four independent
experiments with a p value determined by t test comparing specific signaling with signal obtained from the IgG control (*p < 0.05).
(D) Representative western blot showing a decrease in levels of pSMAD2 at 24 and 72 hr, with an increase in total SMAD2 levels with
shRUNX1 treatment during mesendoderm differentiation.
(E) Quantitation of western blots from four independent experiments. Data represent the mean ± SEM of the ratio of pSMAD2 over total
SMAD2, and there is a significant decrease (*p < 0.05) in the ratio of pSMAD2 to total SMAD2 at 24 and 72 hr of differentiation.
See also Figure S2.motility and EMT gene expression that result from RUNX1
depletion and TGFB2 signaling. Scratch closure assays were
performed to determine whether the effect of RUNX1
depletion on hESC migration could be rescued by TGFB2
(Figure 5A). We found that addition of TGFB2 significantly
increased the extent of scratch closure of the shRUNX1
hESCs from 40% to 60%; TGFB1, which was included
as a control, had no effect (Figure 5B). These findings are
consistent with our discovery that RUNX1 occupies and
transcriptionally activates the TGFB2 gene (Figures 4B
and 4C), and establish that RUNX1 regulation of hESC
migration is mediated through TGFB2.
TGFB signaling can regulate EMT and the associated
changes in cell adhesion and migration (Nieto, 2013;890 Stem Cell Reports j Vol. 7 j 884–896 j November 8, 2016Thiery et al., 2009). Because RUNX1 knockdown inhibits
TGFB signaling (Figure 4), we evaluated whether supple-
mentation of the shRUNX1 cultures with exogenous
TGFB1 or TGFB2 could rescue the altered expression of
EMT genes (Figure 5C). While TGFB2 caused significant
repression of the epithelial markers to levels similar to
those in shNS hESCs, TGFB1 was unable to repress most
of these genes, with the exception of CLDN7 (Figure 5C).
TGFB2 failed to induce expression of ZEB2, the only
mesenchymal marker that was not upregulated during dif-
ferentiation of shRUNX1 hESCs, suggesting that the effect
of TGFB2 is primarily on epithelial markers (Figure 5C).
These findings indicate that knockdown of RUNX1 allevi-
ates repression of epithelial genes (Figure 3), and addition
Figure 5. Defects in Cell Motility and EMT Gene Expression Caused by RUNX1 Depletion Are Rescued by Reintroduction of TGFB2,
but Not TGFB1
(A) Representative phase-contrast images from a scratch closure assay. Assays were carried out as in Figure 2G, with the addition of TGFB
ligand. Dotted lines have been added to the phase-contrast images for emphasis along the edge of the scratch after the 18 h closure period.
All phase-contrast images were taken at 103 magnification.
(B) Percentage of scratch closure for hESCs with non-silencing infection and shRUNX1 infection, as well as shRUNX1 cells supplemented
with exogenous TGFB1 or TGFB2, as quantitated by ImageJ. Ten scratches were measured for each condition, two from each of five
independent experiments, and data represent mean ± SD. p Values were determined by t test (*p < 0.05, ***p < 0.001).
(C) The expression of the four genes that were found to be affected by RUNX1 knockdown (CDH1, OCLN, CLD7, and ZEB2) with non-silencing,
shRUNX1, shRUNX1 + TGFB2, and shRUNX1 + TGFB1 over a mesendoderm differentiation time course. Data are shown as mean ± SEM from
three independent experiments. p Values were determined by t test between shRUNX1 and either shRUNX1 cells supplemented with TGFB2,
or TGFB1 (#p < 0.0001).
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of TGFB2 decreases the expression of these epithelial genes
(Figure 5C). Taken together, our results show that the
selective and transient RUNX1 expression during early
mesendodermal differentiation of hESCs regulates cell
motility and EMT gene expression through TGFB2.DISCUSSION
In this study we discovered unexpected, transient expres-
sion of the phenotypic transcription factor RUNX1 during
early mesendodermal differentiation of hESCs, which
suggested that RUNX1 contributes to differentiation in
addition to its established role in hematopoietic lineage
identity. Our findings showed that RUNX1 regulates cell
motility and gene expression during mesendodermal
differentiation, specifically through TGFB2 signaling.
These results reveal a previously unknown role for
RUNX1 in early development.
The discovery of a burst of RUNX1 expression was both
selective and specific because none of the other examined
phenotypic transcription factors showed increased expres-
sion. RUNX1 expression from the distal P1 promoter is
linked with the emergence of definitive hematopoietic
stem cells (Chen et al., 2009; Lacaud et al., 2002; Okuda
et al., 1996), but little work has been done on the role of
transcripts from the more ubiquitous proximal P2 pro-
moter (Challen and Goodell, 2010; Fujita et al., 2001;
Sroczynska et al., 2009). In this study, the RUNX1 transcript
that we found during early mesendodermal differentiation
is the RUNX1b isoform from the P2 promoter. Of note, in
undifferentiated hESCs the RUNX1 P2 promoter that ex-
presses the RUNX1b transcript is bivalently marked with
H3K27me3 and H3K4me3, indicating that it is poised for
expression, while the P1 promoter is not (Mikkelsen
et al., 2007). Our discovery of a rapid, but substantial in-
crease in RUNX1 expression early in differentiation to
mesendoderm suggests a potential role for RUNX1 that is
unrelated to hematopoiesis (Lian et al., 2003).
We provide evidence that RUNX1 has a role in early mes-
endodermal differentiation of hESCs through regulation of
cell migration and adhesion, as indicated by impairment of
these processes upon RUNX1 depletion. These findings are
consistent with the emerging role of RUNX1 in controlling
cell motility andmigration in other biological systems. Our
laboratory has previously shown that Runx1 depletion in
breast cancer cells results in a decreased migration and in-
vasion phenotype (Browne et al., 2015); similar results
were found in ovarian cancer cells (Keita et al., 2013).
Likewise, Runx1b is responsible for inducing a cell adhe-
sion and migration program prior to release of mouse
hematopoietic stem cells from hemogenic endothelium
(Lie-A-Ling et al., 2014).892 Stem Cell Reports j Vol. 7 j 884–896 j November 8, 2016Gene expression profiling of early mesendodermal differentia-
tion revealed that RUNX1 regulates TGFB signaling, which has
known roles in themaintenanceof pluripotency of hESCs (James
et al., 2005; Wei et al., 2005), differentiation (Itoh et al., 2014;
Watabe andMiyazono, 2009), and EMT (Xu et al., 2009). The in-
hibition ofmotility and derepression of epithelial genes observed
upon RUNX1 depletion indicates that RUNX1 is upstream of
the TGFB pathway. Moreover, we found that RUNX1 specifically
occupies and regulates the expression of the TGFB2 gene, which
encodesoneofthethreeTGFBligands.AlthoughtheTGFBligands
share greater than 70% homology (Kingsley, 1994), studies of
knockout mice show non-overlapping phenotypes, indicating
that each ligand has specific functions in development (Sanford
etal.,1997).Consistentwiththeresults fromthesemousemodels,
we found that TGFB2, but not TGFB1, rescued the phenotype of
RUNX1 depletion.
In conclusion, our discovery of RUNX1-mediated regula-
tion of TGFB2 signaling provides mechanistic insights into
early mesendodermal differentiation. These results also
establish RUNX1 as a selective and specific regulator of
cell motility and EMT-associated gene expression.EXPERIMENTAL PROCEDURES
Stem Cell Culture
The female H9 (WA09) line and themale H1 (WA01) of hESCs were
maintained on Matrigel and differentiated as previously reported
(VanOudenhove et al., 2016). In short, mesendoderm differentia-
tion was induced with Knockout DMEM, containing 20% heat-in-
activated defined fetal bovine serum (FBS), 1mML-glutaminewith
1% (v/v) 2-mercaptoethanol, and 0.1 mM non-essential amino
acids. Retinoic acid (RA)-induced ectodermal differentiation was
induced by the addition of 1 mM all-trans retinoic acid (Sigma-
Aldrich). The mesodermal differentiation protocol induces differ-
entiation by introducing medium containing RPMI 1640 with
B-27 supplement without insulin (Life Technologies) and 12 mM
CHIR99021 (Selleck Chemicals, catalog #S2924). For the produc-
tion of endoderm, undifferentiated hESC cultures were switched
to RPMI 1640 containing 13 Glutamax and 100 ng/mL activin A
(R&D Systems); for treatment past 24 hr, 0.2% FBS was added.Lentiviral RNAi
H9 hESCs plated onMatrigel were transduced in 6-well plates with
lentivirus carrying shRNA designed to knock down RUNX1 (clone
V2LHS_150257) or be non-silencing (#RHS4346) using the GIPZ
Lentiviral RNAi System (GE Dharmacon) in the presence of
polybrene. After introduction of lentivirus, cells were spun at
2,000 rpm at 37C for 45 min. Selection with 1 mg/mL puromycin
(Sigma-Aldrich #P7255-100MG) was performed for the first three
passages after infection.Microarray Expression Analysis
RNA was extracted using TRIzol and prepared for microarray anal-
ysis as described previously (VanOudenhove et al., 2016). All target
preparation and microarray hybridization/scanning was per-
formed in the VGN Microarray Facility at the University of
Vermont. The datasets generated have been deposited in the
NCBI GEO database according to MIAME guidelines (GEO:
GSE74004 and GSE79598).
Due to evident fold-change compression, Affymetrix used a GC
content leveling and signal-space transformation to reduce back-
ground levels. Analysis of data was performed using Affymetrix
Expression Console Build 1.3.1.187 and the Affymetrix Transcrip-
tome Analysis Console Version 1.0.0.234. Differential gene expres-
sion was defined as a fold change greater than 1.5, an ANOVA
p value less than 0.05, and an FDR p value less than 0.05. Partek
Genomic Suite software was used to generate the principal compo-
nent analysis. EulerAPE version 3.0.0 was used to generate the pro-
portional Venn diagram and then recolored (Micallef and Rodgers,
2014). Pathway analysis was performed using Ingenuity Pathways
Analysis (Qiagen, www.ingenuity.com). GO term analysis was per-
formed using DAVID (Version 6.7) (Huang da et al., 2009a, 2009b).
The ClueGO plug-in for Cytoscape 2.8 (Version 1.8) was used for
functional grouping GO analysis (Bindea et al., 2009).
Real-Time qPCR Analysis
RNA was isolated as described for microarray analysis, and cDNA
was synthesized with random hexamer primers using SuperScript
III First Strand Synthesis System (Life Technologies #18080-051).
qRT-PCR was performed using SYBR Green PCR Master Mix (Bio-
Rad); samples were normalized to HPRT1 and fold change was
determined using the DDCt method. Primers used are as specified
in Table S1.
Immunofluorescence Microscopy and RNA FISH
Cells were grown on Matrigel-coated coverslips for IF and RNA
FISH. Detection of RUNX1 protein was performed using a rabbit
polyclonal RUNX1 antibody (Cell Signaling #4336). Staining was
performed using a fluorescent secondary antibody to rabbit poly-
clonal antibodies and a goat anti-rabbit immunoglobulin G (IgG)
(H + L) secondary antibody, Alexa Fluor 488 conjugate (Thermo
Fisher Scientific #A-11001). For RNA FISH, a RUNX1 probe was
created using a BAC clone (RP11-299D9) spanning the RUNX1
gene locus, obtained from the BAC/PAC Resources at the Chil-
dren’s Hospital Oakland Research Institute from the RPCI-11
Human Male BAC Library (Osoegawa et al., 1998, 2001). The
BAC clone was amplified and isolated using the Qiagen Large-
Construct Kit, and labeled by nick translation using the DIG-
Nick Translation Mix (Roche #11745816910). Hybridization and
detection were carried out as previously reported (Byron et al.,
2013), with the addition of a pepsin digest (5 mg/mL pepsin in a
1:2,000 dilution in 0.01 N HCl) to allow full penetrance of probe.
Hybridization occurred overnight at 37C. A rhodamine anti-di-
goxygenin secondary antibody (Roche #11207750910) was used
for signal detection. Images were taken on a Zeiss AxioImager
microscope equipped with a Hamamatsu CCD camera and Meta-
morph imaging software.
Proliferation Assays
For growth curves, cells were plated in 12-well plates. The next day,
cells were counted and this value was taken as 0 hr, and differenti-ationwas initiated in half of the plates. Countingwas performed at
the same time daily for up to 120 hr until confluence was reached.
For the BrdU incorporation assay, cells were incubated for 30 min
at 37C with 10 mM BrdU (Roche kit #11296 736 001) to allow for
incorporation before fixation. Fixation was performed using 3.7%
formaldehyde in PBS for 10 min. Cells were then permeabilized in
0.1% Triton X-100 in PBS, and washed in 0.5% BSA in PBS. For the
BrdU incorporation assay, cells were treated with DNaseI (30 mg per
million cells) (BD Biosciences) for 1 hr at 37C after permeabiliza-
tion to expose the incorporated BrdU. Detection was performed
using a mouse monoclonal anti-BrdU antibody (clone MBG 6H8
IgG1 from Roche) and staining was performed using a mouse
monoclonal F(ab0)2 goat anti-mouse IgG (H + L) secondary anti-
body and Alexa Fluor 647 conjugate (Life Technologies #A-21237).
Western Blot
Whole-cell lysates were generated by incubating cells in RIPA
buffer for 30 min on ice, followed by sonication using a Covaris
S-220 Ultrasonic Processor for 5 min. Lysates were separated in
an 8% polyacrylamide gel and transferred to polyvinylidene
fluoride membranes (Millipore) using an OWL semi-dry transfer
apparatus. Membranes were blocked using 1% Blotting Grade
Blocker Non-Fat Dry Milk (Bio-Rad) and incubated overnight at
4C with the following primary antibodies: a rabbit polyclonal
RUNX1 (Cell Signaling #4334, 1:1,000); a goat polyclonal to
POU5F1 (Santa Cruz Biotechnology #sc-8628, 1:1,000); a rabbit
polyclonal to CDK2 (M2) (Santa Cruz #sc-163, 1:2,000); a mouse
monoclonal to GAPDH (0411) (Santa Cruz #sc-47724); a rabbit
monoclonal to SMAD2 (D43B4) (Cell Signaling #5339); and a
rabbit monoclonal to pSMAD2 (Ser465/467) (138D4) (Cell
Signaling #3108). Secondary antibodies conjugated to horseradish
peroxidase (Santa Cruz) were used for immunodetection, along
with the Clarity Western ECL Substrate (Bio-Rad) on a Chemidoc
XRS+ imaging system (Bio-Rad).
TGFB Rescues
Reintroduction of TGFB1 (R&D Systems #240-B) and TGFB2 (R&D
Systems #302-B2) reconstituted in 4 mM HCl was performed at
5.0 ng/mL.
Scratch Assays
hESCs were plated and 24 hr later were induced to differentiate,
and 30 hr into differentiationmitomycin C at 10 mg/mL was intro-
duced to inhibit cell proliferation. After 48 hr of differentiation,
colonies were scratched down the center using a sterile 10-mL
pipette tip. Scratches were imaged by phase-contrast microscopy
directly in the center of the colony, after being washed twice
with medium, and marked. The scratch was imaged 18 hr later in
the marked location. The scratch area was calculated using the
Scratch Assay Analyzer plug-in from MiToBo toolbox for ImageJ
(Glaß et al., 2012).
Chromatin Immunoprecipitation
After 2 days of mesendodermal differentiation, cells were cross-
linked with 0.8% formaldehyde (Sigma-Aldrich) in PBS for
10 min. The cells were washed twice and lysed in a buffer contain-
ing 0.1% sodium deoxycholate, 0.5% N-lauroylsarcosine, 1 mMStem Cell Reports j Vol. 7 j 884–896 j November 8, 2016 893
EDTA, 1mMEGTA, 10mMTris-HCl (pH 8), and 13 protease inhib-
itor mixture. Lysates were sonicated to fragment chromatin DNA
into 200–800 bp pieces using an S220 Sonicator (Covaris).
Lysates were transferred into a buffer containing 0.1% SDS,
1 mM EDTA, 50 mM HEPES (pH 7.9), 140 mM NaCl, 1% Triton
X-100, and 13 protease inhibitor mixture. Sheared chromatin
was used for immunoprecipitation with RUNX1 antibody (Cell
Signaling #4334) or IgG (Millipore #12-370) overnight at 4C.
Subsequently, the immunoprecipitation mixture was incubated
with Protein-G Dynabeads (Thermo Fisher #10003D) for an
additional 3 hr at 4C. Precipitated chromatin was washed with
salt solutions of increasing concentration, and eluted into a buffer
containing 1% SDS and 0.1 M NaHCO3. The crosslinking
was reversed and DNA was recovered using the QiaQuick PCR
purification kit (Qiagen #28104).
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